Xiling Jiang
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Stephan Schmidt (2 shared papers)Lawrence J. Lesko (2 shared papers)Weirong Wang (5 shared papers)Honghui Zhou (4 shared papers)Marc Robert Theoret (5 shared papers)Richard Pazdur (4 shared papers)Jiang Liu (3 shared papers)Kirsten B. Goldberg (2 shared papers)
- Journals
- Clinical Cancer Research (6 papers)European Journal of Pharmaceutical Sciences (2 papers)The Oncologist (1 paper)Clinical Pharmacology & Therapeutics (1 paper)mAbs (1 paper)
- Partner nations
- United StatesChinaNetherlands
In The Last Decade
Xiling Jiang
19 papers receiving 700 citations
Peers
Comparison fields: 5 of 60
- Hepatology 87
- Pharmacology 93
- Oncology 113
- Cardiology and Cardiovascular Medicine 116
- Cancer Research 64
Countries citing papers authored by Xiling Jiang
This map shows the geographic impact of Xiling Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiling Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiling Jiang more than expected).
Fields of papers citing papers by Xiling Jiang
This network shows the impact of papers produced by Xiling Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiling Jiang. The network helps show where Xiling Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiling Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 158 | |
| 2 | 2020 | 152 | |
| 3 | 2020 | 131 | |
| 4 | 2018 | 44 | |
| 5 | 2016 | 39 | |
| 6 | 2020 | 36 | |
| 7 | 2016 | 31 | |
| 8 | 2015 | 27 | |
| 9 | 2018 | 21 | |
| 10 | 2020 | 21 | |
| 11 | 2023 | 18 | |
| 12 | 2023 | 14 | |
| 13 | 2020 | 9 | |
| 14 | 2024 | 7 | |
| 15 | 2015 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2025 | 2 | |
| 18 | 2024 | 1 | |
| 19 | 2025 | 1 |
About Xiling Jiang
Xiling Jiang is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Pharmacology, Statistics and Probability and Pediatrics, Perinatology and Child Health, having authored 19 papers that have together received 719 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Acute Myeloid Leukemia Research (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Statistical Methods in Clinical Trials (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Pharmaceutical studies and practices (2 papers). The work is most often cited by research in Hepatology (87 citations), Pharmacology (93 citations), Oncology (113 citations), Cardiology and Cardiovascular Medicine (116 citations) and Cancer Research (64 citations). Xiling Jiang has collaborated with scholars based in United States, China and Netherlands. Frequent co-authors include Stephan Schmidt, Lawrence J. Lesko, Weirong Wang, Honghui Zhou, Marc Robert Theoret, Richard Pazdur, Jiang Liu, Kirsten B. Goldberg, Martha Boeri Donoghue and Sandra J. Casak. Their work appears in journals such as Clinical Cancer Research, European Journal of Pharmaceutical Sciences, The Oncologist, Clinical Pharmacology & Therapeutics and mAbs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.